Advertisement
Advertisement
U.S. markets close in 4 hours 35 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Theravance Biopharma, Inc. (TBPH)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
9.29-0.07 (-0.75%)
As of 11:25AM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Fast Stochastic

Fast Stochastic

Previous Close9.36
Open9.21
Bid9.25 x 1400
Ask9.27 x 1400
Day's Range9.11 - 9.34
52 Week Range6.10 - 14.28
Volume75,943
Avg. Volume938,769
Market Cap710.009M
Beta (5Y Monthly)0.68
PE Ratio (TTM)N/A
EPS (TTM)-2.02
Earnings DateNov 01, 2022 - Nov 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.57
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for TBPH

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Theravance Biopharma, Inc.
    Analyst Report: Merck & Co IncMerck & Co. is a worldwide pharmaceutical company. Its major drugs include treatments in oncology and diabetes. The company also has a leading vaccine business and an animal health division. MRK shares are included in the S&P 500.
    Rating
    Fair Value
    Economic Moat
    9 days agoArgus Research
View more
Advertisement
Advertisement